Novo Integrated jumps on Health Canada's license to commercialize iodine oral spray

Novo Integrated Sciences

23/12/2021 13:50

** Novo Integrated Sciences' shares  NVOS.O  jump 9.3% to
$1.52 premarket
    ** Co says Health Canada granted wholly owned subsidiary
Novo Healthnet a natural product number (NPN) -- a license to
commercialize -- for IoNovo Iodine  urn:newsml:reuters.com:*:nBwb4ttlRa
    ** IoNovo Iodine oral spray is a daily-use micronutrient
    ** Up to Wednesday's close, stock had fallen 67% YTD

 (Reporting by Leroy Leo)
 ((Leroy.Dsouza@thomsonreuters.com;))